Ma Shanchun, Lei Xiaoping, Tu Jing, Tian Cuiling, Lian Gang, Li Wei, Wang Dingsong
Department of E.N.T, The 3rd Affiliated Hospital of Chengdu Medical College, Pidu District Peopie's Hospital Chengdu 611700, Sichuan, China.
Am J Transl Res. 2021 Apr 15;13(4):3826-3832. eCollection 2021.
This study investigated and analyzed the effects of glucocorticoid infiltration on chronic rhino-sinusitis with nasal polyps (CRSwNP) after endoscopic sinus surgery (ESS) and its curative efficacy on nasal ventilation function and mucociliary clearance (MCC).
126 CRSwNP patients admitted to the hospital from March 2018 to May 2020 were enrolled and randomly divided into observation group (n=65) and control group (n=61) based on random number table. The control group received ESS, and the observation group was given glucocorticoids treatment after ESS. The changes of nasal ventilation function, MCC and quality of life between the two groups of patients before and after treatment were compared.
The overall effective rate of clinical therapy was critically higher in observation group than in control group (). In addition, NMCA and NCV in observation group were critically higher than those in control group (), and nasal airway resistance (NAR) in observation group was notably lower than that in control group (). In addition, the Saccharin removal time in observation group after treatment was remarkably lower than that in control group (), while the speed and rate of MCC were critically higher than those in control group (). Finally, the scores of each dimension of WHOQOL-100 scale in two groups of subjects after treatment were critically higher than those before treatment (), and the scores in observation group were notably higher than those in control group ().
The treatment of glucocorticoid infiltration on CRSwNP after ESS can effectively improve the curative effect. It improves the patient's function of nasal ventilation and MCC, thus beneficial to promoting the sufferers' living quality and is worthy of clinical promotion.
本研究调查并分析了糖皮质激素浸润对鼻内镜鼻窦手术(ESS)后慢性鼻-鼻窦炎伴鼻息肉(CRSwNP)的影响及其对鼻腔通气功能和黏液纤毛清除功能(MCC)的疗效。
选取2018年3月至2020年5月收治的126例CRSwNP患者,根据随机数字表法随机分为观察组(n = 65)和对照组(n = 61)。对照组接受ESS治疗,观察组在ESS术后给予糖皮质激素治疗。比较两组患者治疗前后鼻腔通气功能、MCC及生活质量的变化。
观察组临床治疗总有效率显著高于对照组()。此外,观察组的鼻腔最小横截面积(NMCA)和鼻黏膜容积(NCV)显著高于对照组(),观察组的鼻气道阻力(NAR)显著低于对照组()。另外,观察组治疗后的糖精清除时间显著低于对照组(),而MCC的速度和速率显著高于对照组()。最后,两组患者治疗后WHOQOL-100量表各维度得分均显著高于治疗前(),且观察组得分显著高于对照组()。
ESS术后糖皮质激素浸润治疗CRSwNP可有效提高疗效。它改善了患者的鼻腔通气功能和MCC,从而有利于提高患者的生活质量,值得临床推广。